Cargando…

Disease and Economic Burden Associated with Recurrent Pericarditis in a Privately Insured United States Population

INTRODUCTION: Approximately 30% of patients with a first acute pericarditis episode experience a recurrence ≤ 18 months; ~ 15% experience multiple recurrences. This study assessed the recurrence and economic burden among patients with multiple recurrences. METHODS: Adults with idiopathic pericarditi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, David, Laliberté, François, Majeski, Christine, Magestro, Matt, Lejeune, Dominique, Duh, Mei Sheng, Lim-Watson, Michelle, Paolini, John F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478772/
https://www.ncbi.nlm.nih.gov/pubmed/34417724
http://dx.doi.org/10.1007/s12325-021-01868-7
_version_ 1784576130573926400
author Lin, David
Laliberté, François
Majeski, Christine
Magestro, Matt
Lejeune, Dominique
Duh, Mei Sheng
Lim-Watson, Michelle
Paolini, John F.
author_facet Lin, David
Laliberté, François
Majeski, Christine
Magestro, Matt
Lejeune, Dominique
Duh, Mei Sheng
Lim-Watson, Michelle
Paolini, John F.
author_sort Lin, David
collection PubMed
description INTRODUCTION: Approximately 30% of patients with a first acute pericarditis episode experience a recurrence ≤ 18 months; ~ 15% experience multiple recurrences. This study assessed the recurrence and economic burden among patients with multiple recurrences. METHODS: Adults with idiopathic pericarditis were identified in the OptumHealth Care Solutions, Inc., database (2007–2017). Recurrent pericarditis (RP) was defined as ≥ 2 episodes of care separated by > 28 days; multiple recurrences were defined as ≥ 2 recurrences. RESULTS: Among 944 patients with RP, 375 (39.7%) experienced multiple recurrences and were propensity score-matched 1:1 to 375 patients without recurrence. Among patients with multiple recurrences, median disease duration (time from first episode to end of last recurrence, confirmed by a 1.5-year recurrence-free period) was 2.84 years. The multiple recurrences cohort had higher rates of hospitalizations per-patient-per-month (PPPM) than the no recurrence cohort (rate ratio [95% confidence interval (CI)] = 2.22 [1.35–3.65]). Mean total healthcare costs were significantly higher in the multiple recurrences versus no recurrence cohort ($2728 vs. $1568 PPPM, cost ratio [95% CI] = 1.74 [1.29–2.32]), mainly driven by higher hospitalization costs in the multiple recurrences cohort (mean: $1180 vs. $420 PPPM, cost ratio [95% CI] = 2.81 [1.80–4.66]). Mean work loss costs were higher in the multiple recurrences versus no recurrence cohort ($696 vs. $169 PPPM, cost ratio [95% CI] = 4.12 [1.64–9.61]). In patients with multiple recurrences, mean cost of the first episode was $19,189; subsequent recurrences ranged from $2089 to $7366 (second recurrence = $6222). CONCLUSION: In conclusion, among patients with multiple pericarditis recurrences, disease symptoms persisted several years, and healthcare and work loss costs were further compounded in this subset of patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12325-021-01868-7.
format Online
Article
Text
id pubmed-8478772
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-84787722021-10-08 Disease and Economic Burden Associated with Recurrent Pericarditis in a Privately Insured United States Population Lin, David Laliberté, François Majeski, Christine Magestro, Matt Lejeune, Dominique Duh, Mei Sheng Lim-Watson, Michelle Paolini, John F. Adv Ther Original Research INTRODUCTION: Approximately 30% of patients with a first acute pericarditis episode experience a recurrence ≤ 18 months; ~ 15% experience multiple recurrences. This study assessed the recurrence and economic burden among patients with multiple recurrences. METHODS: Adults with idiopathic pericarditis were identified in the OptumHealth Care Solutions, Inc., database (2007–2017). Recurrent pericarditis (RP) was defined as ≥ 2 episodes of care separated by > 28 days; multiple recurrences were defined as ≥ 2 recurrences. RESULTS: Among 944 patients with RP, 375 (39.7%) experienced multiple recurrences and were propensity score-matched 1:1 to 375 patients without recurrence. Among patients with multiple recurrences, median disease duration (time from first episode to end of last recurrence, confirmed by a 1.5-year recurrence-free period) was 2.84 years. The multiple recurrences cohort had higher rates of hospitalizations per-patient-per-month (PPPM) than the no recurrence cohort (rate ratio [95% confidence interval (CI)] = 2.22 [1.35–3.65]). Mean total healthcare costs were significantly higher in the multiple recurrences versus no recurrence cohort ($2728 vs. $1568 PPPM, cost ratio [95% CI] = 1.74 [1.29–2.32]), mainly driven by higher hospitalization costs in the multiple recurrences cohort (mean: $1180 vs. $420 PPPM, cost ratio [95% CI] = 2.81 [1.80–4.66]). Mean work loss costs were higher in the multiple recurrences versus no recurrence cohort ($696 vs. $169 PPPM, cost ratio [95% CI] = 4.12 [1.64–9.61]). In patients with multiple recurrences, mean cost of the first episode was $19,189; subsequent recurrences ranged from $2089 to $7366 (second recurrence = $6222). CONCLUSION: In conclusion, among patients with multiple pericarditis recurrences, disease symptoms persisted several years, and healthcare and work loss costs were further compounded in this subset of patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12325-021-01868-7. Springer Healthcare 2021-08-21 2021 /pmc/articles/PMC8478772/ /pubmed/34417724 http://dx.doi.org/10.1007/s12325-021-01868-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Lin, David
Laliberté, François
Majeski, Christine
Magestro, Matt
Lejeune, Dominique
Duh, Mei Sheng
Lim-Watson, Michelle
Paolini, John F.
Disease and Economic Burden Associated with Recurrent Pericarditis in a Privately Insured United States Population
title Disease and Economic Burden Associated with Recurrent Pericarditis in a Privately Insured United States Population
title_full Disease and Economic Burden Associated with Recurrent Pericarditis in a Privately Insured United States Population
title_fullStr Disease and Economic Burden Associated with Recurrent Pericarditis in a Privately Insured United States Population
title_full_unstemmed Disease and Economic Burden Associated with Recurrent Pericarditis in a Privately Insured United States Population
title_short Disease and Economic Burden Associated with Recurrent Pericarditis in a Privately Insured United States Population
title_sort disease and economic burden associated with recurrent pericarditis in a privately insured united states population
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478772/
https://www.ncbi.nlm.nih.gov/pubmed/34417724
http://dx.doi.org/10.1007/s12325-021-01868-7
work_keys_str_mv AT lindavid diseaseandeconomicburdenassociatedwithrecurrentpericarditisinaprivatelyinsuredunitedstatespopulation
AT lalibertefrancois diseaseandeconomicburdenassociatedwithrecurrentpericarditisinaprivatelyinsuredunitedstatespopulation
AT majeskichristine diseaseandeconomicburdenassociatedwithrecurrentpericarditisinaprivatelyinsuredunitedstatespopulation
AT magestromatt diseaseandeconomicburdenassociatedwithrecurrentpericarditisinaprivatelyinsuredunitedstatespopulation
AT lejeunedominique diseaseandeconomicburdenassociatedwithrecurrentpericarditisinaprivatelyinsuredunitedstatespopulation
AT duhmeisheng diseaseandeconomicburdenassociatedwithrecurrentpericarditisinaprivatelyinsuredunitedstatespopulation
AT limwatsonmichelle diseaseandeconomicburdenassociatedwithrecurrentpericarditisinaprivatelyinsuredunitedstatespopulation
AT paolinijohnf diseaseandeconomicburdenassociatedwithrecurrentpericarditisinaprivatelyinsuredunitedstatespopulation